vs
Concrete Pumping Holdings, Inc.（BBCP）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是Concrete Pumping Holdings, Inc.的1.3倍（$127.1M vs $98.9M），再鼎医药同比增速更快（17.1% vs -3.2%），Concrete Pumping Holdings, Inc.自由现金流更多（$1.9M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 4.8%）
Concrete Pumping Holdings, Inc.是领先的混凝土泵送服务及相关设备租赁供应商，主要面向美国和英国市场，业务覆盖基础设施建设、商业地产开发、住宅建造等核心建筑领域，为各类项目提供高效安全的混凝土输送解决方案。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
BBCP vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.3倍
$98.9M
营收增速更快
ZLAB
高出20.3%
-3.2%
自由现金流更多
BBCP
多$28.6M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
4.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $98.9M | $127.1M |
| 净利润 | $5.3M | — |
| 毛利率 | 43.8% | 51.0% |
| 营业利润率 | 17.0% | -54.6% |
| 净利率 | 5.4% | — |
| 营收同比 | -3.2% | 17.1% |
| 净利润同比 | -43.6% | — |
| 每股收益（稀释后） | $0.09 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBCPZLAB
| Q4 25 | $98.9M | $127.1M | ||
| Q3 25 | $94.2M | $115.4M | ||
| Q2 25 | $85.2M | $109.1M | ||
| Q1 25 | $78.0M | $105.7M | ||
| Q4 24 | $102.1M | $108.5M | ||
| Q3 24 | $100.6M | $101.8M | ||
| Q2 24 | $98.7M | $100.1M | ||
| Q1 24 | $90.0M | $87.1M |
净利润BBCPZLAB
| Q4 25 | $5.3M | — | ||
| Q3 25 | $3.7M | $-36.0M | ||
| Q2 25 | $-4.0K | $-40.7M | ||
| Q1 25 | $-2.6M | $-48.4M | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $7.6M | $-41.7M | ||
| Q2 24 | $3.0M | $-80.3M | ||
| Q1 24 | $-3.8M | $-53.5M |
毛利率BBCPZLAB
| Q4 25 | 43.8% | 51.0% | ||
| Q3 25 | 42.9% | 59.5% | ||
| Q2 25 | 42.5% | 60.6% | ||
| Q1 25 | 40.0% | 63.6% | ||
| Q4 24 | 45.3% | 61.5% | ||
| Q3 24 | 44.3% | 64.1% | ||
| Q2 24 | 42.3% | 64.9% | ||
| Q1 24 | 37.0% | 61.4% |
营业利润率BBCPZLAB
| Q4 25 | 17.0% | -54.6% | ||
| Q3 25 | 13.7% | -42.3% | ||
| Q2 25 | 9.7% | -50.3% | ||
| Q1 25 | 4.5% | -53.3% | ||
| Q4 24 | 18.8% | -62.6% | ||
| Q3 24 | 16.5% | -66.6% | ||
| Q2 24 | 12.2% | -76.0% | ||
| Q1 24 | 1.6% | -80.7% |
净利率BBCPZLAB
| Q4 25 | 5.4% | — | ||
| Q3 25 | 3.9% | -31.2% | ||
| Q2 25 | -0.0% | -37.3% | ||
| Q1 25 | -3.4% | -45.8% | ||
| Q4 24 | 9.2% | — | ||
| Q3 24 | 7.5% | -40.9% | ||
| Q2 24 | 3.1% | -80.2% | ||
| Q1 24 | -4.3% | -61.4% |
每股收益（稀释后）BBCPZLAB
| Q4 25 | $0.09 | $-0.05 | ||
| Q3 25 | $0.07 | $-0.03 | ||
| Q2 25 | $-0.01 | $-0.04 | ||
| Q1 25 | $-0.06 | $-0.04 | ||
| Q4 24 | $0.16 | $-0.09 | ||
| Q3 24 | $0.13 | $-0.04 | ||
| Q2 24 | $0.05 | $-0.08 | ||
| Q1 24 | $-0.08 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $44.4M | $689.6M |
| 总债务越低越好 | $417.9M | — |
| 股东权益账面价值 | $264.8M | $715.5M |
| 总资产 | $879.5M | $1.2B |
| 负债/权益比越低杠杆越低 | 1.58× | — |
8季度趋势，按日历期对齐
现金及短期投资BBCPZLAB
| Q4 25 | $44.4M | $689.6M | ||
| Q3 25 | $41.0M | $717.2M | ||
| Q2 25 | $37.8M | $732.2M | ||
| Q1 25 | $85.1M | $757.3M | ||
| Q4 24 | $43.0M | $779.7M | ||
| Q3 24 | $26.3M | $616.1M | ||
| Q2 24 | $18.0M | $630.0M | ||
| Q1 24 | $14.7M | $650.8M |
总债务BBCPZLAB
| Q4 25 | $417.9M | — | ||
| Q3 25 | $417.6M | — | ||
| Q2 25 | $417.3M | — | ||
| Q1 25 | $417.1M | — | ||
| Q4 24 | $373.3M | — | ||
| Q3 24 | $372.9M | — | ||
| Q2 24 | $372.6M | — | ||
| Q1 24 | $372.2M | — |
股东权益BBCPZLAB
| Q4 25 | $264.8M | $715.5M | ||
| Q3 25 | $261.3M | $759.9M | ||
| Q2 25 | $261.8M | $791.7M | ||
| Q1 25 | $260.7M | $810.8M | ||
| Q4 24 | $321.7M | $840.9M | ||
| Q3 24 | $314.7M | $667.7M | ||
| Q2 24 | $308.3M | $704.2M | ||
| Q1 24 | $307.9M | $762.2M |
总资产BBCPZLAB
| Q4 25 | $879.5M | $1.2B | ||
| Q3 25 | $886.0M | $1.2B | ||
| Q2 25 | $878.8M | $1.2B | ||
| Q1 25 | $912.9M | $1.2B | ||
| Q4 24 | $898.0M | $1.2B | ||
| Q3 24 | $890.8M | $985.3M | ||
| Q2 24 | $894.7M | $987.4M | ||
| Q1 24 | $894.8M | $988.4M |
负债/权益比BBCPZLAB
| Q4 25 | 1.58× | — | ||
| Q3 25 | 1.60× | — | ||
| Q2 25 | 1.59× | — | ||
| Q1 25 | 1.60× | — | ||
| Q4 24 | 1.16× | — | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 1.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.5M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $1.9M | $-26.7M |
| 自由现金流率自由现金流/营收 | 1.9% | -21.0% |
| 资本支出强度资本支出/营收 | 12.7% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.72× | — |
| 过去12个月自由现金流最近4个季度 | $17.5M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流BBCPZLAB
| Q4 25 | $14.5M | $-26.0M | ||
| Q3 25 | $19.1M | $-32.0M | ||
| Q2 25 | $24.7M | $-31.0M | ||
| Q1 25 | $6.0M | $-61.7M | ||
| Q4 24 | $22.4M | $-55.8M | ||
| Q3 24 | $35.0M | $-26.8M | ||
| Q2 24 | $9.1M | $-42.2M | ||
| Q1 24 | $20.3M | $-90.1M |
自由现金流BBCPZLAB
| Q4 25 | $1.9M | $-26.7M | ||
| Q3 25 | $4.3M | $-35.0M | ||
| Q2 25 | $11.1M | $-33.9M | ||
| Q1 25 | $191.0K | $-63.2M | ||
| Q4 24 | $16.1M | $-58.4M | ||
| Q3 24 | $26.4M | $-28.2M | ||
| Q2 24 | $-1.9M | $-42.9M | ||
| Q1 24 | $2.5M | $-91.1M |
自由现金流率BBCPZLAB
| Q4 25 | 1.9% | -21.0% | ||
| Q3 25 | 4.6% | -30.4% | ||
| Q2 25 | 13.0% | -31.1% | ||
| Q1 25 | 0.2% | -59.9% | ||
| Q4 24 | 15.8% | -53.8% | ||
| Q3 24 | 26.2% | -27.7% | ||
| Q2 24 | -1.9% | -42.9% | ||
| Q1 24 | 2.8% | -104.5% |
资本支出强度BBCPZLAB
| Q4 25 | 12.7% | 0.5% | ||
| Q3 25 | 15.7% | 2.6% | ||
| Q2 25 | 16.0% | 2.6% | ||
| Q1 25 | 7.5% | 1.5% | ||
| Q4 24 | 6.2% | 2.4% | ||
| Q3 24 | 8.6% | 1.3% | ||
| Q2 24 | 11.2% | 0.7% | ||
| Q1 24 | 19.7% | 1.1% |
现金转化率BBCPZLAB
| Q4 25 | 2.72× | — | ||
| Q3 25 | 5.16× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 4.63× | — | ||
| Q2 24 | 3.00× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BBCP
| US Concrete Pumping | $72.2M | 73% |
| US Concrete Waste Management Services | $21.3M | 22% |
| Other | $5.4M | 5% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
